LABA/LAMA vs placebo
FEV1 · Adults with COPD
1 finding from 1 review
- Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for… 2019 · Cochrane Headline outcomes onlyno estimate extracted13 studies · 6598 participantsModerate